Hydrocortisone Sodium Succinate Injection Shortage

Last Updated: August 15, 2025
Status: Current

Limited Availability, Current:

• Solu-cortef, Injection, 100 mg/vial (Hospira, Inc., a Pfizer Company)
• Solu-cortef, Injection, 1000 mg/vial (Hospira, Inc., a Pfizer Company)
• Solu-cortef, Injection, 250 mg/vial (Hospira, Inc., a Pfizer Company)
• Solu-cortef, Injection, 500 mg/vial (Hospira, Inc., a Pfizer Company)

Solu-cortef, Injection, 100 mg/vial (Hospira, Inc., a Pfizer Company)

NDC Code: 0009-0825-01
Availability: Limited Availability
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Limited Supply Available. Next Delivery: August 2025; Estimated Recovery: September 2025
Therapeutic category: Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology
Initial posting date: March 24, 2023
Contact info: 844-646-4398
Related info link: https://www.fda.gov/media/187228/download

Solu-cortef, Injection, 100 mg/vial (Hospira, Inc., a Pfizer Company)

NDC Code: 0009-0011-04
Availability: Limited Availability
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: Limited Supply Available. Next Delivery: August 2025; Estimated Recovery: September 2025
Therapeutic category: Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology
Change date: December 19, 2024
Initial posting date: March 24, 2023
Contact info: 844-646-4398
Related info link: https://www.fda.gov/media/187228/download

Solu-Cortef, Injection, 100 mg/vial (Hospira, Inc., a Pfizer Company)

NDC Code: 0009-0011-03
Availability: Limited Availability
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Demand increase for the drug
Related Information: Limited Supply Available. Next Delivery: August 2025; Estimated Recovery: September 2025
Therapeutic category: Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology
Change date: December 19, 2024
Initial posting date: March 24, 2023
Contact info: 844-646-4398
Related info link: https://cdernexus.fda.gov/suite/sites/dsm/page/home

Solu-cortef, Injection, 1000 mg/vial (Hospira, Inc., a Pfizer Company)

NDC Code: 0009-0005-01
Availability: Limited Availability
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Limited Supply Available. Next Delivery: August 2025; Estimated Recovery: September 2025
Therapeutic category: Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology
Initial posting date: March 24, 2023
Contact info: 844-646-4398

Solu-cortef, Injection, 250 mg/vial (Hospira, Inc., a Pfizer Company)

NDC Code: 0009-0013-06
Availability: Limited Availability
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Limited Supply Available. Next Delivery: August 2025; Estimated Recovery: September 2025
Therapeutic category: Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology
Initial posting date: March 24, 2023
Contact info: 844-646-4398

Solu-cortef, Injection, 250 mg/vial (Hospira, Inc., a Pfizer Company)

NDC Code: 0009-0013-05
Availability: Limited Availability
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Limited Supply Available. Next Delivery: August 2025; Estimated Recovery: September 2025
Therapeutic category: Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology
Initial posting date: March 24, 2023
Contact info: 844-646-4398

Solu-cortef, Injection, 500 mg/vial (Hospira, Inc., a Pfizer Company)

NDC Code: 0009-0016-12
Availability: Limited Availability
Status: Current
Date of update: August 15, 2025
Update type: Revised
Reason for shortage: Other
Related Information: Limited Supply Available. Next Delivery: August 2025; Estimated Recovery: September 2025
Therapeutic category: Pulmonary/Allergy; Dermatology; Endocrinology/Metabolism; Gastroenterology; Hematology; Neurology; Oncology; Ophthalmology; Pediatric; Renal; Rheumatology
Initial posting date: March 24, 2023
Contact info: 844-646-4398

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer